The purpose of this study is to evaluate participation in an 8-week community-based, online program for adults that will help them make small changes to their diet, physical activity, and other behaviors to help promote their health or manage their weight. We are interested in who will participate, how much participants will use the program, how many participants are interested in preventing weight gain or losing weight, and how the program will affect eating, physical activity, and stress. This program is based on previous research on approaches the researchers have studied to help people make small changes to their behavior and is being offered in response to an identified need to offer health promotion resources during the COVID-19 pandemic

There are currently two common follow-up plans for patients that discover they have a pancreatic cyst. One plan has the patient seen more frequently and the other less frequently. This study attempts to answer the question of which approach is better by randomly assigning each participant to a plan and following them for 5 years.

The purpose of this research study is to deliver 6 months of 1:1 health coaching to cancer patients being treated at UNC Cancer Hospital. This program hopes to improve patient's self-confidence and satisfaction with how they feel and what they are able to do day-to-day. This includes exercising, support for healthy eating, emotional and social needs. Health coaching means you will receive weekly phone calls and emails from a trained coach.

Do you have Peripheral T Cell Lymphoma? Has your cancer come back or did it not get better with the last treatment you were given? If so, you may be eligible to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.

Have you been diagnosed with pancreatic cancer? If so, you may be able to take part in a research study looking at the efficacy of neoadjuvant FOLFIRINOX in subjects with non-metastatic pancreatic cancer.

Have you been diagnosed with multiple myeloma or high-risk smoldering multiple myeloma? If so, you may be able to take part in a research study looking at how drugs used to treat multiple myeloma work.

Researchers are studying different doses of a therapy (CD19 CAR T-cells) to find the dose that is both the most effective and the safest for patients with relapsed or refractory B-cell lymphoma.

Do you have Hodgkin's Lymphoma or Cutaneous T-Cell Lymphoma? Has your lymphoma come back, or has it not gotten better after your last treatment? If so, you might be able to take part in a study that will modify your own immune cells to see if it may treat your lymphoma.

Have you been diagnosed with a plasma cell disorder? You may be able to join a registry to help us learn more about the effects of plasma cell disorders on different aspects of life.

Have you been diagnosed with melanoma? If so, you may be eligible to take part in a research study looking at the safety of giving a combination of drugs called Ulixertinib and Palbociclib to patients with advanced melanoma.